New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 3, 2014
08:17 EDTCPIXCumberland acquires Vaprisol from Astellas Pharma US
Cumberland Pharmaceuticals announced the acquisition of Vaprisol from Astellas Pharma US. Vaprisol is a patented, prescription brand indicated to raise serum sodium levels in hospitalized patients with hyponatremia. Under the terms of the agreement, Cumberland will assume full responsibility for the product including its marketing, distribution and manufacture.
News For CPIX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 25, 2016
08:05 EDTCPIXCumberland and Piramal launch co-promotion of Caldolor and Vaprisol
Piramal Critical Care, an integral business unit of Piramal Enterprises and Cumberland Pharmaceuticals announced that they have officially launched co-promotion of two of Cumberland's branded hospital products, Caldolor and Vaprisol throughout the U.S. Caldolor, ibuprofen, Injection is the first injectable product approved in this country for the treatment of pain and fever in adults. The brand recently received FDA approval for the management of pain and reduction of fever use in pediatric patients six months and older. Vaprisol is the only injectable brand available to treat hyponatremia, the most common electrolyte imbalance in U.S. hospitalized patients.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use